Closing Care Gaps with Wearables

Why It Matters

Embedding care navigation into wearables can accelerate diagnosis, improve outcomes, and reduce costly delays, positioning the device market as a true partner in value‑based care.

Key Takeaways

• ACC urges wearable firms to embed care navigation tools.
• Seamless referrals can reduce delays in diagnosis and treatment.
• Data standards essential for interoperability across EHRs.
• Partnerships with providers boost user trust and adoption.
• Regulatory guidance may shape future wearable care pathways.

Pulse Analysis

The wearable health market is exploding, with devices now capable of monitoring heart rhythm, blood pressure, and even early markers of atrial fibrillation. Analysts project that by 2030 more than 200 million U.S. adults will regularly use a health‑focused wearable, generating a flood of real‑time biometric data. While these insights promise earlier detection of cardiovascular disease, the value is limited unless the data translate into actionable clinical steps.

Dr. Ami Bhatt’s call to action reflects a growing consensus that device makers must become care coordinators, not just data collectors. Embedding referral pathways—such as one‑click appointments with cardiologists, automated alerts to primary‑care EHRs, and personalized education modules—can bridge the current chasm. Early pilots that integrate wearables with health‑system portals have shown a 20% reduction in time to diagnosis for high‑risk patients, underscoring the tangible benefits of a seamless handoff from consumer to clinician.

The industry response is already shifting toward partnership models. Major manufacturers are striking deals with health systems, insurers, and telehealth platforms to embed clinical workflows directly into their apps. At the same time, standards bodies like HL7 and the FDA are drafting guidance to ensure data interoperability and patient safety. As regulatory clarity improves, wearables that provide built‑in care navigation are poised to capture a larger share of the value‑based care market, turning raw biometric streams into measurable health outcomes.